HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Pasteurella multocida bacterin-toxoid

effective against atrophic rhinitis

Also Known As:

Pm bacterin-toxoid

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Bacterial Vaccines: 529
      - Pasteurella multocida bacterin-toxoid: 3

Experts

1.	Confer, Anthony W: 1 article (07/2008)
2.	Cook, Billy J: 1 article (07/2008)
3.	Ingram, Shan H: 1 article (07/2008)
4.	Kirkpatrick, John G: 1 article (07/2008)
5.	McTague, Lawrence F: 1 article (07/2008)
6.	Payton, Mark E: 1 article (07/2008)
7.	Richards, Jeffrey B: 1 article (07/2008)
8.	Saliki, Jeremiah T: 1 article (07/2008)
9.	Step, Douglas L: 1 article (07/2008)
10.	Wright, John C: 1 article (07/2008)

Related Diseases

1.	Diarrhea 05/01/2008 - "At the time of allocation, 1 group (MLV3-BT2) received a multivalent, modified-live viral vaccine containing infectious bovine rhinotracheitis virus (IBRV) and types I and II bovine viral diarrhea virus (BVDV), as well as a Mannheimia haemolytica (MH) and Pasteurella multocida bacterin-toxoid. " 07/01/2008 - "Calves were vaccinated with a modified-live infectious bovine rhinotracheitis virus (IBRV), bovine viral diarrhea virus types 1 (BVDV1) and 2 (BVDV2), parainfluenza type 3 virus, and bovine respiratory syncytial virus vaccine and Mannheimia haemolytica and Pasteurella multocida bacterin-toxoid at approximately 67 and 190 days of age (group 1; n = 151) or at approximately 167 and 190 days of age (group 2; 150) or were not vaccinated (control; 150). "
2.	Paramyxoviridae Infections (Parainfluenza) 07/01/2008 - "Calves were vaccinated with a modified-live infectious bovine rhinotracheitis virus (IBRV), bovine viral diarrhea virus types 1 (BVDV1) and 2 (BVDV2), parainfluenza type 3 virus, and bovine respiratory syncytial virus vaccine and Mannheimia haemolytica and Pasteurella multocida bacterin-toxoid at approximately 67 and 190 days of age (group 1; n = 151) or at approximately 167 and 190 days of age (group 2; 150) or were not vaccinated (control; 150). "
3.	Atrophic Rhinitis (Ozena) 01/01/1997 - "Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. "
4.	Infections 01/01/1997 - "Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. "

Related Drugs and Biologics

1.	Viral Vaccines
2.	Vaccines